1. Recent Funding
2. Investors
3. Farallon Capital Management

Farallon Capital Management has backed 1 company on Recent Funding, 0 in the last 12 months; its most recent deal is Parabilis Medicines (2021-03-01).

What Farallon Capital Management invests in

• Health and bio · 1 · 100%

How Farallon Capital Management invests

Share is of the 1 round on Recent Funding that name Farallon Capital Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with Farallon Capital Management	Total raised	Latest raise
PParabilis Medicines Health and bio	Mar 1, 2021 Series b+ · $107M	$801M	Jan 8, 2026 Series b+

Most frequent co-investors

• GGV1 shared round · last Mar 1, 2021
• TT. Rowe Price Associates1 shared round · last Mar 1, 2021
• 66 Dimensions Capital1 shared round · last Mar 1, 2021
• BBlue Pool Capital1 shared round · last Mar 1, 2021
• DDeerfield Management1 shared round · last Mar 1, 2021
• VvenBio Partners1 shared round · last Mar 1, 2021
• CCormorant Asset Management1 shared round · last Mar 1, 2021
• IInvus1 shared round · last Mar 1, 2021
• HHBM Healthcare Investments1 shared round · last Mar 1, 2021
• CCasdin Capital1 shared round · last Mar 1, 2021
• PPagsGroup1 shared round · last Mar 1, 2021

Portfolio companies are the companies on Recent Funding with a round that lists Farallon Capital Management, which is a subset of its real portfolio. API: /api/v1/investors/farallon-capital-management. All investors.